Connection

Otavio Berwanger to Angiotensin Receptor Antagonists

Back to Details
This is a "connection" page, showing publications Otavio Berwanger has written about Angiotensin Receptor Antagonists.
Otavio Berwanger
Connection Strength
0.058
Angiotensin Receptor Antagonists
  1. Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial. Am Heart J. 2019 01; 207:40-48.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.